Protagonist Therapeutics (PTGX) PT Raised to $100 at TD Cowen
Tweet
Share
E-mailGet Alerts PTGX Hot Sheet
Price: $155.10 +2.43%
Rating Summary:
20 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
20 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
TD Cowen analyst Tara Bancroft raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $100.00 (from $90.00) while maintaining a rating.
You May Also Be Interested In
- Protagonist Therapeutics (PTGX) PT Raised to $170 at Truist Securities
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
